November 20, 2020 at 4:18 am

Hair-Loss Drug & Suicidality Side Effects

“Young men using the hair loss drug finasteride, sold under brand-name Propecia, may be at higher risk of experiencing depression, anxiety, and suicidal thoughts,” a new Boston study finds. Researchers identified 356 reports of suicidality, and almost 3,000 reports of other psychological symptoms among men taking finasteride.

Read the full article at

November 19, 2020 at 12:51 pm

Kids at Risk of Polypharmacy Harms

Despite limited evidence of efficacy and mounting safety concerns, “the use of medication from 2 or more psychotropic classes, i.e., polypharmacy, has increased among US youths,” finds a recent study published in JAMA Pediatrics. Polypharmacy increases the risks of serious adverse drug effects, such as akathisia, delirium, and mania, that can cause suicidality.

Get the full story at

October 14, 2020 at 11:06 am

Zoom with MISSD on Oct. 18th

Adverse drug effects, suicidality, addiction, and mental well being are just a few topics to be addressed by Wendy Dolin and other experts by experience from 9 to 11 on October 18th. The program is free and more details are available at

September 29, 2020 at 2:38 pm

A Podcast to Save Lives

“The combination of the inner signs, the outer signs, and the cognitive confusion makes this a very profound, underreported side effect.” –Wendy Dolin, MISSD Founder

Listen to The Divorce and Beyond podcast about akathisia, advocacy, and the tragic loss that led to MISSD.

September 28, 2020 at 6:18 am

Today: MISSD Founder Discusses Akathisia & Advocacy on Popular Podcast

This show “could save your life or the life of someone you love,” says Susan Guthrie, nationally recognized family law attorney, mediator, and host of the popular podcast, “The Divorce and Beyond.” This morning Guthrie talks with MISSD founder, Wendy Dolin, about akathisia and advocacy. The two-part series will also be available on Spotify, iTunes, and similar channels.

Listen at

September 25, 2020 at 7:55 am

Royal College of Psychiatrists Add Akathisia Info

A new publication to help people safely withdraw from antidepressants has been published by the Royal College of Psychiatrists (RCP). The “Antidepressant Withdrawal” leaflet specifically mentions akathisia and suicidal thoughts as symptoms of antidepressant withdrawal. RCP defines akathisia as “a feeling of inner restlessness and inability to stay still (akathisia).”

MISSD presented at the Royal College of Psychiatrists’ (RCP) 2019 International Congress in London. RCP’s then-president said they were developing new akathisia education for its members. MISSD is pleased RCP published the “Antidepressant Withdrawal” leaflet and we hope to soon see RCP’s new akathisia education for prescribers and patients.

To read and share RCP’s Antidepressant Withdrawal leaflet, visit

To view and share MISSD’s RCP presentation, visit

September 24, 2020 at 2:31 pm

FDA Updates Benzo Risk Info

“The current labeling information on the drugs “does not provide adequate warnings about these serious risks and harms associated with these medicines,” the F.D.A.’s announcement said.”

Adverse drug effects associated with benzodiazepine includes akathisia.

Read the full story at

September 22, 2020 at 6:02 pm

Antidepressants & Evidence-Based Medicine

A report by Public Health England found prescriptions for drugs marketed as antidepressants have doubled in the last 10 years, and similarly high prescribing rates are likely found in the US.

“Although national guidelines tend to recommend antidepressants primarily for moderate to severe depression, research tells us that millions of people with mild depression, or understandable grief following losses, are being prescribed these drugs,” said Dr. John Read, Professor of Clinical Psychology at the University of East London.

It’s important to be aware that possible adverse drug effects of SSRIs include ‘suicidality’ (reported by 50%) and difficulties in withdrawing from SSRIs (reported by 59%).

If you are experiencing difficulties withdrawing from SSRIs, and/or are suffering from withdrawal akathisia, check out these online resources run by ‘experts-by-experience’, including www.letstalkwithdrawal (UK) and (USA).

Read the full article at

September 20, 2020 at 7:07 am

Nobody is Immune to Akathisia

It’s Suicide Prevention Month and MISSD again designates today, September 20th, as International Akathisia Awareness Day. Sharing accurate info can save lives.

“Suicide prevention organizations and crisis hotlines can help reduce these avoidable deaths by asking questions about medications and adverse drug effects,” said MISSD founder Wendy Dolin. “Nobody is immune to akathisia.”


September 15, 2020 at 3:26 pm

MISSING: Transparence in Clinical Drug Trials

Whether it’s acne drugs, anxiety drugs, asthma drugs or possible COVID-19 cures, MISSD believes transparency in sharing clinical trial data is necessary to reduce adverse drug effects and related deaths.

Read the full Kaiser Health News article at